Congestive Heart Failure
Written by recognized leaders in the field, Congestive Heart Failure, Third Edition is a comprehensive, state-of-the-art reference on all basic and clinical aspects of heart failure. Coverage includes an entire section on pharmacologic therapy and a twenty-chapter section on clinical approaches to acute and chronic heart failure.
This edition has new chapters on impact and treatment of comorbidities, prevention of sudden cardiac death, rationale for use of anticoagulants, ultrafiltration, use of mechanical devices, and gene and cell therapy. Readers will find up-to-date information on genetics, surgical therapies, ventricular synchronization, defibrillator therapy, mechanical approaches to atrial fibrillation, left ventricular assist devices, ventricular support and ventricular remodeling surgery, and myocardial regeneration/cell transplantation.
|Autore:||Hosenpud J.D. MD, Greenberg B.H. MD|
2006, Pages: 845, Illustrations: 463, Trim Size: 8.5 x 11
|Casa Editrice:||Lippincott Williams & Wilkins|
EPIDEMIOLOGY AND PATHOPHYSIOLOGY OF HEART FAILURE: Epidemiology of Heart Failure / Cellular and Molecular Abnormalities in Cardiac Myocytes / Progression from Cardiac Hypertrophy to Heart Failure / Cytoskeletal Abnormalities in Myocytes During Heart Failure / Abnormalities in Calcium Cycling in Heart Failure / Abnormalities in Cardiac Contraction: Systolic Dysfunction / Heart Failure with Normal Ejection Fraction / Cellular, Molecular, and Structural Changes During Cardiac Remodeling / Remodeling of the Cardiac Interstitium in Heart Failure / Role of the Renin-Angiotensin-Aldosterone System / Sympathetic Nervous System in Heart Failure / Other Neurohormonal Systems / Cytokine Activity in Heart Failure / The Peripheral Circulation in Heart Failure / The Kidney in Heart Failure
DIFFERENTIAL DIAGNOSIS OF CONGESTIVE HEART FAILURE: Risk Factors For Developing Heart Failure / Heart Failure Secondary to Coronary Artery Disease / The Cardiomyopathic and Inflammatory Diseases / Heart Failure as a Consequence of Valvular Heart Disease / Heart Failure Secondary to Congenital Heart Disease / Right Heart Failure / Heart Failure in Cardiac Tamponade, Constrictive Pericarditis and Restrictive Cardiomyopathy
PHARMACOLOGIC THERAPY OF HEART FAILURE: Clinical Pharmacokinetics in Heart Failure / Traditional Diuretics and Other Diuresing Agents / Digitalis Glycosides / Inhibition of the Renin-Angiotensin-Aldosterone System / Non-ACE Inhibitor Vasodilators / Beta-Blocker Therapy of Heart Failure / Inotropic Agents
CLINICAL APPROACH TO ACUTE AND CHRONIC HEART FAILURE: Primary Prevention of Heart Failure / Physical Examination in Heart Failure / Natriuretic Peptides as Bio-Markers to Detect, Risk Stratify and Manage Patients with Heart Failure / The Non-invasive Diagnostic Assessment of Patients with CHF / Catheter-Based Assessment and Therapy in Congestive Heart Failure / Management of Acute and Decompensated Heart Failure / Integrating Pharmacologic Therapy in Chronic CHF / Biventricular Pacing in Congestive Heart Failure / Developing an Outpatient Heart Failure Clinic / Exercise and Rehabilitation in Congestive Heart Failure / Impact and Treatment of Comorbidities in Heart Failure / Management of Supraventricular Arrhythmias in Patients with Congestive Heart Failure / Prevention of Sudden Cardiac Death / Theory and Rationale for the Use of Anticoagulants in Heart Failure / Ultrafiltration for Congestive Heart Failure / Surgical Approaches to Patients with Chronic Congestive Heart Failure / Use of Mechanical Devices in Treating Heart Failure / Cardiac Transplantation / Strategies for Gene and Cell Therapy in Heart Failure / End of Life Decisions / What Does the Future Hold?